Samsung Biologics Co Ltd

Common Name
Samsung Biologics
Country
South Korea
Sector
Healthcare
Industry
Biotechnology
Employees
4,770
Ticker
207940
Exchange
KOREA EXCHANGE
Description
Samsung Biologics Co., Ltd. is a key player in the biopharmaceutical manufacturing and services industry. Established as a subsidiary of Samsung Group, it focuses on the development and manufacturing ...

Samsung Biologics Waste Data Preview

In 2023, Samsung Biologics conducted an environmental assessment and disclosed corporate waste management data in accordance with recognized sustainability reporting standards. The company provided a breakdown of its waste by type (hazardous vs non-hazardous) and treatment method (recovery vs disposal), enabling greater transparency into its waste handling and environmental practices.

Metric (tonnes)2024202320222021 - 2017
Total Waste Generated
0000000
Copy restricted. Please purchase to unlock this data.
Copy restricted. Please purchase to unlock this data.
0000000
Total Waste Recovered
0000000
Copy restricted. Please purchase to unlock this data.
Copy restricted. Please purchase to unlock this data.
0000000
Total Hazardous Waste Generated
0000000
Copy restricted. Please purchase to unlock this data.
Copy restricted. Please purchase to unlock this data.
0000000
Non-Hazardous Waste Disposed
0000000
Copy restricted. Please purchase to unlock this data.
Copy restricted. Please purchase to unlock this data.
0000000

This table provides a simplified preview of selected waste data points. To access the complete dataset with full disclosures and structure, create a free account to purchase the full dataset.

Insights into Samsung Biologics's Waste Treatment Practices

In 2023, Samsung Biologics generated a total of 10,676 metric tonnes of waste.

Of this amount, 83.81% of Samsung Biologics's total waste generated was recovered through methods such as recycling, reuse, or composting, while 16.19% was disposed of through landfilling, incineration, or combustion.

Samsung Biologics's Waste Recovery Rate

84%

How much of Samsung Biologics's waste is recycled or recovered?

In 2023, Samsung Biologics reported a total waste generation of 10,676 metric tonnes, of which 83.81% was recovered through recycling, reuse, or composting. This high recovery rate suggests that Samsung Biologics has implemented strong circular economy practices and actively prioritizes sustainable waste management.

Has Samsung Biologics reduced its environmental waste footprint over time?

Since 2021, Samsung Biologics's total waste generation increased by 27.52%, including a 4.42% increase in 2023, indicating a persistent upward trend that may reflect scaling operations, inefficiencies in resource use, or a lack of effective waste minimization practices.

Over the same period, Samsung Biologics's waste recovery rate increased by 14.6%, including a 12.71% rise in 2023, indicating growing emphasis on circularity and improved operational practices for diverting waste from disposal.

Overall, Samsung Biologics has seen a consistent rise in waste generation both over the long term and in the year 2023. However, the company has also steadily improved its waste recovery performance, suggesting that it is actively working to offset the environmental consequences of increased production through enhanced circularity efforts.

Samsung Biologics’s Waste Recovery vs. Disposal Over Time

20212022202303 k6 k9 k12 ktonnes
  • Total Waste Disposed
  • Total Waste Recovered

Insights into Samsung Biologics’s Generation of Hazardous and Non-Hazardous Waste

In 2023, Samsung Biologics generated a total of 10,676 metric tonnes of waste.

Of this amount, 14.66% of Samsung Biologics's total waste generated of was classified as hazardous waste, characterized by properties such as toxicity, flammability, corrosiveness, or reactivity that may pose risks to human health, ecosystems, or the environment. 85.34% was identified as non-hazardous waste, generally considered less harmful and subject to lighter regulatory controls.

Samsung Biologics’s Hazardous vs Non-Hazardous Waste Over Time

20212022202303 k6 k9 k12 ktonnes
  • Total Non-Hazardous Waste Generated
  • Total Hazardous Waste Generated

How Samsung Biologics reduced the environmental impact of its waste?

Since 2021, Samsung Biologics's total waste generation increased by 27.52%, including a 4.42% rise in 2023, reflecting a persistent upward trend that could be linked to operational growth, inefficient material use, or limited investment in waste prevention systems.

Over the same period, the share of hazardous waste in Samsung Biologics's total output increased by 87.73%, including a further 34.11% rise in 2023, suggesting a troubling upward shift toward more environmentally harmful waste streams that could raise compliance costs and environmental risks.

Overall, Samsung Biologics has seen a continuous rise in both total waste and hazardous waste over time, signaling a worsening environmental impact that may require urgent reassessment of material sourcing, production processes, or waste mitigation strategies.

How does Samsung Biologics treat its hazardous waste?

In 2023, Samsung Biologics reported that 1,565 metric tonnes of its total waste output were classified as hazardous. This represents 14.66% of its overall waste generation.

The company treated this hazardous waste using a combination of methods. Only 3.83% of hazardous waste was recovered, meaning the vast majority was treated through disposal methods such as landfilling or incineration. This raises concerns about the environmental and health risks associated with Samsung Biologics’s current hazardous waste practices.

Breakdown of Samsung Biologics's Hazardous and Non-Hazardous Waste by Treatment Method

Hazardous WasteDisposed(14.1%)Non-Hazardous WasteRecovered(83.2%)
Want Full Access to Samsung Biologics's Waste Management Dataset?
Sign Up